Omnia Education: Exclusively Women’s Health Education - Omnia Education

Exclusively Women’s Health Education

Exclusively Women’s Health Education

Enhance your practice with CME
and tools that focus on diseases and
conditions impacting the female patient.

Popular

From Abstract to Action in Breast Cancer: Interpreting Recent Data on Oral SERDs and Endocrine Targeting Strategies
From Abstract to Action in Breast Cancer: Interpreting Recent Data on Oral SERDs and Endocrine Targeting Strategies
MinuteCE®
From Abstract to Action in Breast Cancer: Interpreting Recent Data on Oral SERDs and Endocrine Targeting Strategies
Aditya Bardia, MD, MPH, FASCO; Erica L. Mayer, MD, MPH
0.50 program credits
- Aditya Bardia, MD, MPH, FASCO
- Erica L. Mayer, MD, MPH
0.50 program credits
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
MinuteCE®
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
Aditya Bardia, MD, MPH, FASCO
0.50 program credits
- Aditya Bardia, MD, MPH, FASCO
0.50 program credits
MinuteCE®
Rapid Data Pulses From ASCO 2026: Emerging Data on Oral Targeted Strategies in Breast Cancer
Aditya Bardia, MD, MPH, FASCO; Erica L. Mayer, MD, MPH
0.50 credits 4 episodes
- Aditya Bardia, MD, MPH, FASCO
- Erica L. Mayer, MD, MPH
0.50 credits 4 episodes
CME/CE In-Person Event
22nd Annual Women’s Health Annual Visit (WHAV)
December 04, 2026
New York, New York
6.00 credits
Shared Goals, Shared Gains: Align With Patient Preferences
Shared Goals, Shared Gains: Align With Patient Preferences
MinuteCE®
Shared Goals, Shared Gains: Align With Patient Preferences
Christyn Edmundson, MD; Gil I. Wolfe MD, FAAN
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit
The IgG Clock: Redose Using IgG Kinetics
The IgG Clock: Redose Using IgG Kinetics
MinuteCE®
The IgG Clock: Redose Using IgG Kinetics
Christyn Edmundson, MD; Gil I. Wolfe MD, FAAN
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit
Target Locked in gMG: Why T2T Matters
Target Locked in gMG: Why T2T Matters
MinuteCE®
Target Locked in gMG: Why T2T Matters
Christyn Edmundson, MD; Gil I. Wolfe MD, FAAN
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit
FcRn: Same Class, Different Paths—Spot Agent Differentiators
FcRn: Same Class, Different Paths—Spot Agent Differentiators
MinuteCE®
FcRn: Same Class, Different Paths—Spot Agent Differentiators
Christyn Edmundson, MD; Gil I. Wolfe MD, FAAN
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit

CME/CE

ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
MinuteCE®
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Aditya Bardia, MD, MPH, FASCO
0.50 program credits
- Aditya Bardia, MD, MPH, FASCO
0.50 program credits
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
MinuteCE®
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
Erica L. Mayer, MD, MPH
0.50 program credits
- Erica L. Mayer, MD, MPH
0.50 program credits
Escalate With Intention: Stepwise, Target-Anchored Moves
Escalate With Intention: Stepwise, Target-Anchored Moves
MinuteCE®
Escalate With Intention: Stepwise, Target-Anchored Moves
Christyn Edmundson, MD; Gil I. Wolfe MD, FAAN
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
MinuteCE®
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
Christyn Edmundson, MD
1.00 program credit
- Christyn Edmundson, MD
1.00 program credit
Turning Flares Into Function: Flag Uncontrolled Disease
Turning Flares Into Function: Flag Uncontrolled Disease
MinuteCE®
Turning Flares Into Function: Flag Uncontrolled Disease
Christyn Edmundson, MD; Gil I. Wolfe MD, FAAN
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit
When to Begin FcRn: Initiation Criteria, Key Evidence
When to Begin FcRn: Initiation Criteria, Key Evidence
MinuteCE®
When to Begin FcRn: Initiation Criteria, Key Evidence
Christyn Edmundson, MD; Gil I. Wolfe MD, FAAN
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit
MinuteCE®
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
Christyn Edmundson, MD; Gil I. Wolfe MD, FAAN
1.00 credit 10 episodes
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 credit 10 episodes
Precision Starts Before Birth: Reimagining Fetal Care Through FcRn Immune Modulation
Precision Starts Before Birth: Reimagining Fetal Care Through FcRn Immune Modulation
CME/CE
Precision Starts Before Birth: Reimagining Fetal Care Through FcRn Immune Modulation
Kenneth J. Moise Jr., MD; Kara B. Markham, MD
0.25 credits
- Kenneth J. Moise Jr., MD
- Kara B. Markham, MD
0.25 credits

Clinical Practice

The 2-Point Signal: Apply ≥2-Point Rule
The 2-Point Signal: Apply ≥2-Point Rule
MinuteCE®
The 2-Point Signal: Apply ≥2-Point Rule
Christyn Edmundson, MD; Gil I. Wolfe MD, FAAN
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit
The Alloimmune Disorders of Pregnancy
The Alloimmune Disorders of Pregnancy
MinuteCE®
The Alloimmune Disorders of Pregnancy
Karin J. Blakemore, MD; Emilie L. Vander Haar
1.00 program credit
- Karin J. Blakemore, MD
- Emilie L. Vander Haar
1.00 program credit
MinuteCE®
Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Overcoming Diagnostic and Therapeutic Challenges
Karin J. Blakemore, MD; Emilie L. Vander Haar
1.00 credit 10 episodes
- Karin J. Blakemore, MD
- Emilie L. Vander Haar
1.00 credit 10 episodes
Clinical Considerations for the Diagnosis of Endometriosis
Clinical Considerations for the Diagnosis of Endometriosis
MinuteCE®
Clinical Considerations for the Diagnosis of Endometriosis
Linda Bradley, MD; James A. Simon, MD, CCD, NCMP, IF, FACOG
1.75 program credits
- Linda Bradley, MD
- James A. Simon, MD, CCD, NCMP, IF, FACOG
1.75 program credits
Strategies to Address Healthcare Disparities in Patients With Endometriosis
Strategies to Address Healthcare Disparities in Patients With Endometriosis
MinuteCE®
Strategies to Address Healthcare Disparities in Patients With Endometriosis
Linda Bradley, MD; Melissa Simon, MD
1.75 program credits
- Linda Bradley, MD
- Melissa Simon, MD
1.75 program credits
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
MinuteCE®
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP; Sawsan As-Sanie, MD
1.75 program credits
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
- Sawsan As-Sanie, MD
- James A. Simon, MD, CCD, NCMP, IF, FACOG
1.75 program credits
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
MinuteCE®
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
Linda Bradley, MD; Melissa Simon, MD
1.75 program credits
- Linda Bradley, MD
- Melissa Simon, MD
- Casey Joe Hinds
1.75 program credits
MinuteCE®
Changing the Mindset in the Management of Endometriosis: Hitting the Pause Button on Surgical Procedures and Expanding the Role of GnRH Antagonists
Lee P. Shulman, MD, FACMG, FACOG; Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
1.75 credits 10 episodes
- Lee P. Shulman, MD, FACMG, FACOG
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
- Sawsan As-Sanie, MD
- Linda Bradley, MD
- James A. Simon, MD, CCD, NCMP, IF, FACOG
- Melissa Simon, MD
- Samantha Denäe
- Casey Joe Hinds
1.75 credits 10 episodes

Programs

Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
MinuteCE®
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP; James A. Simon, MD, CCD, NCMP, IF, FACOG
1.75 program credits
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
- James A. Simon, MD, CCD, NCMP, IF, FACOG
1.75 program credits
The Integral Role of GnRH Antagonists in the Management of Endometriosis
The Integral Role of GnRH Antagonists in the Management of Endometriosis
MinuteCE®
The Integral Role of GnRH Antagonists in the Management of Endometriosis
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP; Sawsan As-Sanie, MD
1.75 program credits
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
- Sawsan As-Sanie, MD
- James A. Simon, MD, CCD, NCMP, IF, FACOG
1.75 program credits
Pre- and Postoperative Use of GnRH Antagonists
Pre- and Postoperative Use of GnRH Antagonists
MinuteCE®
Pre- and Postoperative Use of GnRH Antagonists
Lee P. Shulman, MD, FACMG, FACOG; Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
1.75 program credits
- Lee P. Shulman, MD, FACMG, FACOG
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
1.75 program credits
Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
MinuteCE®
Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
Lee P. Shulman, MD, FACMG, FACOG; Linda Bradley, MD
1.75 program credits
- Lee P. Shulman, MD, FACMG, FACOG
- Linda Bradley, MD
1.75 program credits
Alloimmune Neutropenia of the Fetus and Newborn
Alloimmune Neutropenia of the Fetus and Newborn
CME/CE
Alloimmune Neutropenia of the Fetus and Newborn
Lee P. Shulman, MD, FACMG, FACOG; Masja de Haas, MD, PhD
- Lee P. Shulman, MD, FACMG, FACOG
- Masja de Haas, MD, PhD
Alloimmune Thrombocytopenia in the Fetus and Newborn
Alloimmune Thrombocytopenia in the Fetus and Newborn
CME/CE
Alloimmune Thrombocytopenia in the Fetus and Newborn
Lee P. Shulman, MD, FACMG, FACOG; James B. Bussel, MD
0.25 credits
- Lee P. Shulman, MD, FACMG, FACOG
- James B. Bussel, MD
0.25 credits
Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
CME/CE
Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
Lee P. Shulman, MD, FACMG, FACOG; Kenneth J. Moise Jr., MD
- Lee P. Shulman, MD, FACMG, FACOG
- Kenneth J. Moise Jr., MD
Unmasking Preeclampsia, the Great Masquerader
Unmasking Preeclampsia, the Great Masquerader
Clinician's Roundtable
Unmasking Preeclampsia, the Great Masquerader
Mario R. Nacinovich, Jr., MSc; Kara Rood, MD
- Mario R. Nacinovich, Jr., MSc
- Kara Rood, MD